SGRF appoints Dr. Rajani Kanth Vangala as full time Director

SciGenom Research Foundation (SGRF) has announced the appointment of Dr. Rajani Kanth Vangala as its full time Director.

He will lead the scientific and outreach activities of the foundation and oversee its day to day activities. Dr. Vangala brings over 15 years of experience in translational research and technology development. He will be based at the SGRF lab in Narayana Health City at Bangalore.

Dr. Vangala most recently served as a director and head of translational research at the Thrombosis Research Institute (TRI). His primary research focus has been discovery of biomarkers for risk prediction, diagnostics and translating them into clinically useful tools using nanotechnology.

His approach to translational research also included knowledge translation, technology development and teaching / training M.Sc and Ph.D students. He has over twenty peer reviewed publications and a patent pending to his credit along with several presentations at national and international conferences.

"We are happy to have Dr. Vangala lead SGRF," said Sam Santhosh, Trustee of the SciGenom Research Foundation).

"Dr. Vangala's extensive research and technology background, will help us develop new strategic research alliances across India," added Sam.

"My focus will be to carry forward the strong research culture of SGRF and to develop insights that will be beneficial to our society," said Dr Vangala who has obtained his Ph.D in Hemato-oncology from the Ludwig Maximillians University, Munich, Germany.